Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New multidimensional strategy aims to tame hypertension and diabetes in brazil

NCT ID NCT05660928

Disease control Sponsor: Federal University of Minas Gerais Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested a comprehensive strategy to help manage high blood pressure and diabetes in primary care clinics in Brazil. Over 5,800 adult patients from resource-limited areas took part. The strategy included telehealth tools, education for healthcare workers, and support for patients. The goal was to see if this approach could help more patients get their blood pressure and blood sugar under control compared to usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidimensional intervention (telehealth tools, education, multidisciplinary care)
What this could lead to
If successful, this approach could improve blood pressure and blood sugar control in low-resource primary care settings, offering a model for better chronic disease management.
What could go wrong
This is a completed implementation study, not a drug trial. Results may not apply to other regions or healthcare systems. The intervention is complex and may be hard to replicate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

5,862 people

The number who actually took part.

Started

Dec 2022

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Primary Health Care - Basic health unit with internet availability and complete team, including a Brazilian doctor or with a proficiency test in the Portuguese language. Patients \- Adult patients (from 18 years-old), diagnosed with hypertension and/or DM, registered in the medical record. Subproject cluster randomised controlled trial. All of the above criteria and the following additional criteria: * Patients aged ≥ 18 years-old, with a diagnosis of hypertension and diabetes mellitus, registered in the medical record; * Absence of contraindications to physical activity, according to the assistant physician's assessment; * In intervention levels II and III, it will be a prerequisite that the participant has a smartphone. Exclusion Criteria: * Patients with terminal illness, with a life expectancy lower than 12 months according to the physician's evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arterial hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arterial hypertension Diabetes mellitus

Contacts and locations

Locations

  • Federal University of Minas Gerais

    Belo Horizonte, Minas Gerais, 30130-100, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.